Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ZIPRASIDONE Cause Product substitution issue? 33 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Product substitution issue have been filed in association with ZIPRASIDONE (ziprasidone hydrochloride). This represents 0.9% of all adverse event reports for ZIPRASIDONE.

33
Reports of Product substitution issue with ZIPRASIDONE
0.9%
of all ZIPRASIDONE reports
0
Deaths
2
Hospitalizations

How Dangerous Is Product substitution issue From ZIPRASIDONE?

Of the 33 reports, 2 (6.1%) required hospitalization, and 1 (3.0%) were considered life-threatening.

Is Product substitution issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ZIPRASIDONE. However, 33 reports have been filed with the FAERS database.

What Other Side Effects Does ZIPRASIDONE Cause?

Drug ineffective (958) Suicide attempt (656) Sedation (547) Dyskinesia (527) Sexual dysfunction (497) Dystonia (489) Blood prolactin abnormal (476) Anosognosia (420) Metabolic disorder (418) Blood glucose increased (415)

What Other Drugs Cause Product substitution issue?

AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (2,832) BUPROPION (1,578) METHYLPHENIDATE (1,408) CLONAZEPAM (1,288) LAMOTRIGINE (979) ALBUTEROL (864) LEVOTHYROXINE (803) DULOXETINE (766) ESTRADIOL (692) SERTRALINE (636)

Which ZIPRASIDONE Alternatives Have Lower Product substitution issue Risk?

ZIPRASIDONE vs ZIPRASIDONE\ZIPRASIDONE ZIPRASIDONE vs ZITHROMAX ZIPRASIDONE vs ZIV-AFLIBERCEPT ZIPRASIDONE vs ZOCOR ZIPRASIDONE vs ZOFENOPRIL

Related Pages

ZIPRASIDONE Full Profile All Product substitution issue Reports All Drugs Causing Product substitution issue ZIPRASIDONE Demographics